Most side effects are mild and improve as your body adjusts, especially during dose increases
No observa directamente inflamacin lobulillar, balonizacin hepatocitaria o arquitectura fibrtica
The presence of multiple cardiovascular risk factors strengthens the indication for pharmacotherapy-assisted weight management
Mounjaro is intended for long-term use, but if you are unable to lose at least 5% of your starting weight loss within 6 months of titrating (gradually increasing your dose) to the maximum dose, your doctor may advise you to stop using it or try a different weight loss treatment
Additionally, long-term follow-up studies evaluating dosing, treatment patterns, and real-world effectiveness among patients with T2D initiating tirzepatide could help in optimal use of antihyperglycemic treatment for better management of T2D
Compounding is permitted under defined federal and state-law conditions, but compounded GLP-1 products don't undergo FDA premarket approval, and the circumstances under which copies of commercially available drugs may be legally compounded are specifically restricted - particularly now that semaglutide and tirzepatide supply shortages have resolved